Recent national and regional drug reforms in Sweden: implications for pharmaceutical companies in Europe.
Pharmacoeconomics. 2008;26(7):537-50. doi: 10.2165/00019053-200826070-00001.
Pharmacoeconomics. 2008.
PMID: 18563945
Review.